siRNA treatment reduces triglycerides in patients with unusual condition

.STUDY EMPHASIZE.19 September 2024.

Plozasiran lowered triglyceride levels through 80% and lowered the risk of pancreatitis in individuals with constant chylomicronemia, along with or even without a genetic diagnosis.